Manhattan Hematol Oncol Associates — New York, New York

Manhattan Hematol Oncol Associates is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Manhattan Hematol Oncol Associates has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Chronic Myelogenous Leukemia - Chronic Phase.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Manhattan Hematol Oncol Associates?

Manhattan Hematol Oncol Associates has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Manhattan Hematol Oncol Associates conducted?

Manhattan Hematol Oncol Associates has 1 clinical trials on record, with 1 currently active. Their work covers Chronic Myelogenous Leukemia - Chronic Phase.

Is Manhattan Hematol Oncol Associates accredited by Crixeo Health?

Manhattan Hematol Oncol Associates has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Manhattan Hematol Oncol Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.